US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Global Advantage and Premium Opportunity Fund

9.76

+0.03500.36%

Volume:11.46K

Turnover:111.69K

Market Cap:177.53M

PE:13.97

High:9.81

Open:9.70

Low:9.68

Close:9.72

Loading ...

Overview Company News Filings

Australian Oilseeds Issues Annual Shareholder Letter

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

Press Release: Voya Equity Closed End Funds Declare Distributions

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill

AGS Ignites IGA 2025 with Next-Level Slot & Table Game Innovations

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Press Release: Voya Equity Closed End Funds Declare Distributions

CyberArk Software (CYBR): Among the Best Cybersecurity Stocks to Buy According to Billionaires

Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis

Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Voya Equity Closed End Funds Declare Distributions

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution

CyberArk Acquires Zilla Security to Reshape Identity Governance and Administration for the Modern Enterprise

Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus

Cosmo and Glenmark Announces UK MHRA Approval of Winlevi(R) for Treatment of Acne

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Press Release: Voya Equity Closed End Funds Declare Distributions

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IGA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IGA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IGA\",,,,,undefined,":{"symbol":"IGA","market":"US","secType":"STK","nameCN":"Voya Global Advantage and Premium Opportunity Fund","latestPrice":9.755,"timestamp":1745936920471,"preClose":9.72,"halted":0,"volume":11455,"delay":0,"floatShares":0,"shares":18199252,"eps":0.698293,"marketStatus":"Trading","change":0.035,"latestTime":"04-29 10:31:07 EDT","open":9.7,"high":9.8099,"low":9.6755,"amount":111690.16761,"amplitude":0.013827,"askPrice":9.8,"askSize":500,"bidPrice":9.72,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0.698293,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745956800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":9.72,"aum":0,"dividendRate":0.080984,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":9.72,"preClose":9.72,"latestTime":"08:02 EDT","volume":3,"amount":29.160000000000004,"timestamp":1745928129713},"postHourTrading":{"tag":"盘后","latestPrice":9.72,"preClose":9.72,"latestTime":"16:05 EDT","volume":4,"amount":38.88,"timestamp":1745870709167},"volumeRatio":0.584696},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IGA\",,,,,undefined,":{"symbol":"IGA","floatShares":0,"roa":"1.62%","roe":"6.86%","lyrEps":0.698293,"volumeRatio":0.584696,"shares":18199252,"dividePrice":0.79,"high":9.8099,"amplitude":0.013827,"preClose":9.72,"low":9.6755,"week52Low":8.43,"pbRate":"1.16","psRate":"31.69","week52High":10.02,"institutionHeld":0.214,"latestPrice":9.755,"eps":0.698293,"divideRate":0.080984,"volume":11455,"delay":0,"ttmEps":0.698293,"open":9.7,"prevYearClose":9.2,"prevWeekClose":9.8,"prevMonthClose":9.82,"prevQuarterClose":9.82,"fiveDayClose":9.56,"twentyDayClose":9.82,"sixtyDayClose":9.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IGA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529394879","title":"Australian Oilseeds Issues Annual Shareholder Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2529394879","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529394879?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"COOTAMUNDRA, Australia, April 24, 2025  -- Australian Oilseeds Holdings Limited, a manufacturer and seller of sustainable edible oils to customers globally, today issued a letter to shareholders from Gary Seaton, Chairman and Chief Executive Officer, that highlights recent performance and future milestones.Across the globe, 2024 presented serious challenges including the ongoing war in Ukraine and serious conflicts in the Middle East and growing geopolitical discord, notably with China. Our hearts go out to those whose lives are profoundly affected by these events.Despite the unsettling geopolitical discord, we are pleased with our progress since launching the Company, as a Nasdaq listed company, and its unique products of Non-GMO cold-pressed and chemically-free processed oils.I would like to express my deep gratitude to our Shareholders and our employees. We appreciate your continued support as we continue our exciting journey of taking chemicals out of the food supply chain and prom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/australian-oilseeds-issues-annual-shareholder-120000834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COOT","COOTW","BK4212","IGA"],"gpt_icon":0},{"id":"2529322583","title":"Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529322583","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529322583?lang=en_us&edition=fundamental","pubTime":"2025-04-22 17:30","pubTimestamp":1745314200,"startTime":"0","endTime":"0","summary":"Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse. Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts. Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement. Treatment with LP-310 at the 0.50 mg dose demonstrated statistically significant improvements in multiple patient-reported and investigator-measured efficacy endpoints, reinforcing LP-310’s potential as a non-steroidal, locally delivered therapy for OLP. The trial, currently active across seven U.S. study sites, has now progressed to the third and highest dose cohort , with topline results expected in the second quarter of 2025.LP-310 continues to be well tolerated, with no treatment-related SAEs and no patient dropouts. All participants successfully adhered to the twice-daily 10-milliliter rinse regimen. Pharmacokinetic analysis confirmed that tacrolimus levels remained undetectable or minimal in all patients, reinforcing LP-310’s abil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lipella-reports-positive-phase-2a-093000375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LIPO","IGA","BK4160","BK4139","OLP"],"gpt_icon":0},{"id":"2527206894","title":"Press Release: Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2527206894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527206894?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:30","pubTimestamp":1744749000,"startTime":"0","endTime":"0","summary":"Voya Investment Management, the asset management business of Voya Financial, Inc. , announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund , Voya Global Equity Dividend and Premium Opportunity Fund , Voya Infrastructure, Industrials and Materials Fund , Voya Asia Pacific High Dividend Equity Income Fund , and Voya Emerging Markets High Dividend Equity Fund .With respect to each Fund, the distribution will be paid on May 15, 2025, to shareholders of record on May 1, 2025. The ex-dividend date is May 1, 2025. The distribution per share for each Fund is as follows:. The following table sets forth an estimate of the sources of each Fund's March distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Estimated Sources                             Fiscal YTD                          Estimated F","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4215","IGA","LU1878469433.USD","EQR","BK4022","IDE","BK4184","LU0211331839.USD","BK4585","IGD","IHD","BK4232","IAE","VOYA","R","NAV","LU0061475181.USD"],"gpt_icon":0},{"id":"2527427138","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2527427138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527427138?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:15","pubTimestamp":1744748100,"startTime":"0","endTime":"0","summary":"Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in March 2025. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the April distribution. It is not determinative of the tax character of the Funds' distributions for the 2025 calendar year. Shareholders should note that the Funds' total regular distribution amount is subject to change as a result of market conditions or other factors.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211331839.USD","NAV","IGA","BK4184","BK4544","LU1878469433.USD","BK4588","ARKG","VOYA","FUND","BK4585","IDE","LU0061475181.USD"],"gpt_icon":0},{"id":"2526565249","title":"Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2526565249","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526565249?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:05","pubTimestamp":1744286700,"startTime":"0","endTime":"0","summary":"ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously. 84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin  at Week 16. In the study, 84.1% of adolescent patients treated with once daily icotrokinra achieved an Investigator's Global Assessment b score of 0/1  and 70.5% achieved a Psoriasis Area and Severity Index c 90 response, compared to 27.3% and 13.6% receiving placebo, respectively, at Week 16.1. Response rates continued to improve through Week 24 where 86.4% of adolescents achieved IGA 0/1  and 88.6% achieved PASI 90.1 Further, at Week 24, 75% of adolescents achieved IGA 0  and 63.6% achieved PASI 100.1. \"Adolescents living with moderate to severe plaque psoriasis shouldn't have to wait for effective treatments options that have the potential to deliver complete","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icotrokinra-results-show-75-adolescents-120500105.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icotrokinra-results-show-75-adolescents-120500105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4592","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1221951046.USD","LU2133065610.SGD","LU0345769128.USD","LU0795875169.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","SG9999001440.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU2468319806.SGD","BK4550","LU2602419157.SGD","IE00B3PB1722.GBP","LU0792757196.USD","LU1074936037.SGD","IE00BSNM7G36.USD","LU1066051811.HKD","LU1196500208.SGD","LU1162221912.USD","LU0289739699.SGD","IE00BDGV0183.EUR","LU2129689605.HKD","LU1244550221.USD","LU1732800096.USD","LU1023059063.AUD","LU1430594728.SGD","LU2430703178.SGD","LU0203345920.USD","BK4534","IE00B1BXHZ80.USD","LU1244550577.SGD","LU1059921491.USD","RCT","LU1506573853.SGD","LU2112291526.USD","SG9999002224.SGD","JNJ","IE0002141913.USD","BK4532","IGA","LU2505996509.AUD","LU2129689431.USD","LU1674673428.USD","LU1032466523.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2522051538","title":"AGS Ignites IGA 2025 with Next-Level Slot & Table Game Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2522051538","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522051538?lang=en_us&edition=fundamental","pubTime":"2025-03-28 02:31","pubTimestamp":1743100260,"startTime":"0","endTime":"0","summary":"LAS VEGAS, March  27, 2025  (GLOBE NEWSWIRE) -- AGS (NYSE: AGS), a global leader in gaming solutions, is set to showcase a dynamic array of new products at the 2025 Indian Gaming Association (IGA) tra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/27/3050934/0/en/AGS-Ignites-IGA-2025-with-Next-Level-Slot-Table-Game-Innovations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","IGA","AGS"],"gpt_icon":0},{"id":"2520683236","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2520683236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520683236?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:30","pubTimestamp":1742243400,"startTime":"0","endTime":"0","summary":"VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION. Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in February 2025. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the March distribution. It is not determinative of the tax character of the Funds' distributions for the 2025 calendar year. Shareholders should note that the Funds' total regular distribution amount","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOYA","LU0061475181.USD","BK4184","IDE","LU1878469433.USD","FUND","IGA","LU0211331839.USD","ARKG","NAV"],"gpt_icon":0},{"id":"2520129688","title":"Press Release: Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2520129688","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520129688?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:15","pubTimestamp":1742242500,"startTime":"0","endTime":"0","summary":"Voya Investment Management, the asset management business of Voya Financial, Inc. , announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund , Voya Global Equity Dividend and Premium Opportunity Fund , Voya Infrastructure, Industrials and Materials Fund , Voya Asia Pacific High Dividend Equity Income Fund , and Voya Emerging Markets High Dividend Equity Fund .With respect to each Fund, the distribution will be paid on April 15, 2025, to shareholders of record on April 1, 2025. The ex-dividend date is April 1, 2025. The distribution per share for each Fund is as follows:. The following table sets forth an estimate of the sources of each Fund's February distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Estimated Sources                             Fiscal YTD                      Estima","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGD","LU1878469433.USD","BK4184","IAE","LU0061475181.USD","LU0211331839.USD","BK4585","BK4232","BK4022","BK4588","R","EQR","IDE","BK4215","NAV","IHD","VOYA","IGA"],"gpt_icon":0},{"id":"2518781586","title":"CyberArk Software (CYBR): Among the Best Cybersecurity Stocks to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2518781586","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518781586?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:50","pubTimestamp":1741643413,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Best Cybersecurity Stocks to Buy According to Billionaires. In this article, we are going to take a look at where CyberArk Software Ltd.  stands against other best cybersecurity stocks to buy according to billionaires.The cybersecurity market is poised for significant growth over the coming years, driven by an increasingly complex threat landscape and rapid digital transformation across industries. According to a recent study by Grand View Research Inc., the global cybersecurity market is projected to grow at a compound annual growth rate  of 12.9% from 2025 to 2030. This robust growth is fueled by escalating cyber threats and advanced malware attacks across multiple verticals, including banking, retail, information technology, defense, and manufacturing.In 2024 and into 2025, investments in cyber security are also surging. The Reuters report has highlighted that $4 billion was raised in 2024 by Israeli cybersecurity firms. This underscores that cloud","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cyberark-software-cybr-among-best-215013080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","QLD","SG9999000418.SGD","LU1169589451.USD","SQQQ","LU2125909759.SGD","LU0107464264.USD","LU1559883803.SGD","IGA","LU1169590202.USD","LU2125909916.SGD","CYBR","USJW.SI",".IXIC","CAGR","LU0566484027.USD","LU1923622291.USD","NVIW.SI","LU2286300806.USD","QID","LU2491050071.SGD","LU0053671581.USD","TSYW.SI","LU2491050154.USD","TQQQ","BK4159","BK4097","USAW.SI","MNQmain","LU2491049909.HKD","LU2065731478.USD","BK4560","NQmain"],"gpt_icon":1},{"id":"2517441022","title":"Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441022","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441022?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:00","pubTimestamp":1741442400,"startTime":"0","endTime":"0","summary":"Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm. Nearly half of patients with moderate-to-severe plaque psoriasis  treated with investigational icotrokinra achieved completely clear skin  at Week 24 in Phase 3 ICONIC-LEAD. Topline results from Phase 3 ICONIC-ADVANCE 1&2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO. Data from the Phase 3 ICONIC-LEADa study, presented as a late-breaking abstract at the 2025 American Academy of Dermatology  Annual Meeting, show once daily icotrokinra demonstrated significant skin clearance and a favorable safety profile in adults and adolescents 12 years of age and older with moderate-to-severe plaque PsO.1. \"People living with moderate-to-severe plaque psoriasis are seeking options that balance efficacy, safety and ease of use,\" said Robert Bissonnette, M.D., Chairman at Innovaderm Research, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icotrokinra-results-show-potential-set-140000829.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icotrokinra-results-show-potential-set-140000829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0122379950.USD","LU0795875169.SGD","LU1778281490.HKD","LU0882574055.USD","IE00B1BXHZ80.USD","IGA","LU1261432733.SGD","BK4534","LU0203347892.USD","LU1023059063.AUD","LU1585245621.USD","BK4568","LU2602419157.SGD","LU0345770993.USD","BK4581","LU1066051225.USD","IE00BSNM7G36.USD","LU1244550577.SGD","RCT","LU0889566641.SGD","IE0002270589.USD","JNJ","LU1162221912.USD","BK4533","LU1732799900.SGD","LU0114720955.EUR","LU2468319806.SGD","BK4559","IE00B19Z3B42.SGD","SG9999001440.SGD","LU1221951046.USD","LU0912757837.SGD","IE000M9KFDE8.USD","LU0345769631.USD","BK4588","LU1066051811.HKD","LU2089984988.USD","IE00B19Z3581.USD","LU0203345920.USD","LU1894683348.USD","BK4585","LU2112291526.USD","LU0640476718.USD","IE00BDGV0183.EUR","BK4550","LU1074936037.SGD","LU1506573853.SGD","LU0234570918.USD","LU1280957306.USD"],"gpt_icon":0},{"id":"2516764726","title":"Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2516764726","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516764726?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:03","pubTimestamp":1741093380,"startTime":"0","endTime":"0","summary":"- STAR-1 topline results expected by the end of March 2025 -. - Over 30 million acne patients seek treatment in the U.S. each year -. - XYNGARI Phase 3 STAR-1 trial enrolled 520 patients with moderate-to-severe acne in the U.S. and Latin America -. The XYNGARI Phase 3 STAR-1 clinical study will evaluate the efficacy, safety, and tolerability of XYNGARI in patients with moderate-to-severe facial acne. The STAR-1 study was a randomized (2:1), double-blind, and placebo-controlled study enrolling 520 patients with moderate-to-severe acne, ages 9 years and older in the United States and Latin America. The primary endpoints include the mean change from baseline in inflammatory and noninflammatory lesion counts and the Investigator Global Assessment  treatment response. IGA is measured on a 5-point scale (0-4), with a treatment response defined as at least a 2-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/dermata-announces-last-patient-completes-130300327.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dermata-announces-last-patient-completes-130300327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","DRMA","BK4539","DRMAW","BK4139","IGA"],"gpt_icon":0},{"id":"2514809950","title":"Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809950","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809950?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"Groundbreaking data from first whole body application of QRX003 underscores potential efficacyTransformational improvement in disease state after just 2 weeks of treatment Clear visual evidence of ski","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033744/0/en/Quoin-Pharmaceuticals-Announces-Highly-Positive-Whole-Body-Clinical-Data-from-Ongoing-Pediatric-Netherton-Syndrome-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","BK4139","QNRX"],"gpt_icon":0},{"id":"2512903031","title":"Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2512903031","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512903031?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:30","pubTimestamp":1739914200,"startTime":"0","endTime":"0","summary":"With respect to each Fund, the distribution will be paid on March 17, 2025, to shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025. The distribution per share for each Fund is as follows:. Voya Global Equity Dividend and Premium Opportunity Fund . Voya Asia Pacific High Dividend Equity Income Fund . The following table sets forth an estimate of the sources of each Fund’s January distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Set forth in the tables below is information relating to each Fund’s performance based on its net asset value  for certain periods.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/voya-equity-closed-end-funds-213000770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VOYA","NAV","LU0061475181.USD","BK4588","BK4184","IGA","LU1878469433.USD","IDE","IGD","IAE","EQR","IHD","LU0211331839.USD","BK4585","BK4215"],"gpt_icon":0},{"id":"2512192007","title":"Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192007","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512192007?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:15","pubTimestamp":1739913300,"startTime":"0","endTime":"0","summary":"The amounts and sources of distributions reported in this notice are estimates, are not being provided for tax reporting purposes and the distribution may later be determined to be from other sources including realized short-term gains, long-term gains, to the extent permitted by law, and return of capital. The actual amounts and sources for tax reporting purposes will depend upon the Funds’ investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.Monthly Distribution: Payable February 18, 2025Distribution Amount per Common Share : $0.085Distribution Amount per Common Share : $0.100. The following table sets forth an estimate of the sources of the Fund’s February distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/voya-global-advantage-premium-opportunity-211500687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","VOYA","BK4585","BK4544","NAV","IGA","IDE","ARKG"],"gpt_icon":0},{"id":"2511541378","title":"CyberArk Acquires Zilla Security to Reshape Identity Governance and Administration for the Modern Enterprise","url":"https://stock-news.laohu8.com/highlight/detail?id=2511541378","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511541378?lang=en_us&edition=fundamental","pubTime":"2025-02-13 20:02","pubTimestamp":1739448120,"startTime":"0","endTime":"0","summary":"Industry-leading identity security combined with modern IGA sets a new paradigm for compliance and identity lifecycle management. Under the terms of the agreement, CyberArk has acquired Zilla Security for an enterprise value of $165 million in cash and a $10 million earn-out tied to the achievement of certain milestones.\"As enterprises navigate the proliferation of privilege in complex identity landscapes, modern IGA capabilities become critical for protecting digital assets and maintaining business agility. By expanding the CyberArk Identity Security Platform with Zilla’s modern IGA capabilities, we will reshape identity governance with scalable automation that delivers compliance and helps maximize security for the modern enterprise,\" said Matt Cohen, Chief Executive Officer, CyberArk. \"We’re delighted to welcome Zilla’s co-founders Deepak Taneja and Ni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cyberark-acquires-zilla-security-reshape-120200518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2125909916.SGD","LU0107464264.USD","LU2491049909.HKD","IGA","LU1169589451.USD","LU1559883803.SGD","LU0566484027.USD","LU2491050154.USD","LU2491050071.SGD","BK4097","LU2065731478.USD","LU1923622291.USD","LU2286300806.USD","LU2125909759.SGD","BK4560","CYBR","LU1169590202.USD","LU0053671581.USD","SG9999000418.SGD"],"gpt_icon":0},{"id":"2510809033","title":"Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus","url":"https://stock-news.laohu8.com/highlight/detail?id=2510809033","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510809033?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:46","pubTimestamp":1739270760,"startTime":"0","endTime":"0","summary":"LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3023967/0/en/Lipella-Pharmaceuticals-Reports-Positive-Topline-Phase-2a-Results-for-LP-310-in-the-Treatment-of-Oral-Lichen-Planus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","GRA"],"gpt_icon":0},{"id":"2510886392","title":"Cosmo and Glenmark Announces UK MHRA Approval of Winlevi(R) for Treatment of Acne","url":"https://stock-news.laohu8.com/highlight/detail?id=2510886392","media":"Newsfile","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510886392?lang=en_us&edition=fundamental","pubTime":"2025-02-10 14:02","pubTimestamp":1739167320,"startTime":"0","endTime":"0","summary":"Dublin, Ireland and Mumbai, India and London, United Kingdom-- - Cosmo Pharmaceuticals N.V.    and Glenmark Pharmaceuticals Limited , a global research-led pharmaceutical company, today announced that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency  to market Winlevi in the United Kingdom. Winlevi is a topical treatment for acne vulgaris in patients aged 12 years and older, marking a significant milestone in the commitment of both companies to providing innovative, patient-focused dermatology solutions.“We are excited to receive the approval and bring Winlevi to the UK market, offering patients a new and efficacious treatment for acne,” said Christoph Stoller, President & Business Head – Europe and Emerging Markets, Glenmark Pharmaceuticals. “This approval by the MHRA represents a significant step forward in our mission to enhance dermatology care. Our partnership with Cosmo Pharmaceuticals plays an important role in enabling us to expand our","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cosmo-glenmark-announces-uk-mhra-060200866.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cosmo-glenmark-announces-uk-mhra-060200866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USA","BK4007","BK4232","BK4142","IGA","CMOPF","GHG","BK4022","R"],"gpt_icon":0},{"id":"2503306608","title":"Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2503306608","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503306608?lang=en_us&edition=fundamental","pubTime":"2025-01-16 05:45","pubTimestamp":1736977500,"startTime":"0","endTime":"0","summary":"VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION. Voya Global Advantage and Premium Opportunity Fund  and Voya Infrastructure, Industrials and Materials Fund   today announced important information concerning the Funds' distributions declared in December 2024. This press release is issued as required by the Funds' Managed Distribution Plan  and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the January distribution. It is not determinative of the tax character of the Funds' distributions for the 2024 calendar year. Shareholders should note that the Funds' total regular distribution amou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","FUND","LU1878469433.USD","BK4184","VOYA","IDE","LU0061475181.USD","LU0211331839.USD","NAV","ARKG"],"gpt_icon":0},{"id":"2503706446","title":"Press Release: Voya Equity Closed End Funds Declare Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2503706446","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503706446?lang=en_us&edition=fundamental","pubTime":"2025-01-16 05:30","pubTimestamp":1736976600,"startTime":"0","endTime":"0","summary":"Voya Investment Management, the asset management business of Voya Financial, Inc. , announced today the distributions on the common shares of five of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund , Voya Global Equity Dividend and Premium Opportunity Fund , Voya Infrastructure, Industrials and Materials Fund , Voya Asia Pacific High Dividend Equity Income Fund , and Voya Emerging Markets High Dividend Equity Fund .With respect to each Fund, the distribution will be paid on February 18, 2025, to shareholders of record on February 3, 2025. The ex-dividend date is February 3, 2025. The distribution per share for each Fund is as follows:. The following table sets forth an estimate of the sources of each Fund's December distribution and its cumulative distributions paid this fiscal year to date. Amounts are expressed on a per common share basis and as a percentage of the distribution amount.Estimated Sources                             Fiscal YTD                   ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","R","LU1878469433.USD","BK4232","LU0061475181.USD","NAV","BK4585","IHD","BK4215","IAE","LU0211331839.USD","BK4588","IGD","IGA","BK4184","BK4022","VOYA","IDE"],"gpt_icon":0},{"id":"2503578720","title":"Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578720","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578720?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"Continued Significant Improvement in Skin Appearance Observed in StudySubject’s Disease Classification Improved from “Severe” to “Mild” after 6 Weeks Dosing Treatment area expanded from 20% Body Surfa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009328/0/en/Quoin-Pharmaceuticals-Announces-Further-Positive-Clinical-Data-from-Ongoing-Pediatric-Netherton-Syndrome-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSA","IGA","BK4139","QNRX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IGA\",params:#limit:5,,,undefined,":[{"date":"2025-05-01","symbol":"IGA","amount":0.085,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-01","defaultRemindTime":1746106200000,"name":"IGA基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-01","currency":"USD","dateTimestamp":1746072000000,"payDate":"2025-05-15"},{"date":"2025-04-01","symbol":"IGA","amount":0.085,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"IGA基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-15","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-15"},{"date":"2025-03-03","symbol":"IGA","amount":0.085,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"IGA基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-17","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-17"},{"date":"2025-02-03","symbol":"IGA","amount":0.085,"announcedDate":"2025-01-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-03","defaultRemindTime":1738593000000,"name":"IGA基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-18","payableDate":"2025-02-03","currency":"USD","dateTimestamp":1738558800000,"payDate":"2025-02-18"},{"date":"2024-12-30","symbol":"IGA","amount":0.085,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-30","defaultRemindTime":1735569000000,"name":"IGA基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-15","payableDate":"2024-12-30","currency":"USD","dateTimestamp":1735534800000,"payDate":"2025-01-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IGA\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-07-15","value":0.28,"currency":"USD"},{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-15","value":0.28,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-15","value":0.28,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-15","value":0.28,"currency":"USD"},{"executeDate":"2016-07-01","recordDate":"2016-07-06","paymentDate":"2016-07-15","value":0.28,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IGA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IGA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IGA","date":"2025-04-28","current":16.64857,"percent":0.584767,"low":-51.328749,"twenty":-12.897638,"median":15.213056,"eighty":37.495656,"high":3757.464742,"avg":377.396573,"sd":1083.84212,"marketCap":178352669},"quantilePoints":[{"date":"2020-05-01","current":407.204876,"twenty":5.817568,"median":10.37328,"eighty":53.327598,"marketCap":144792281},{"date":"2020-05-08","current":-48.046097,"twenty":5.812513,"median":10.392706,"eighty":53.820223,"marketCap":147354976},{"date":"2020-05-15","current":-46.01682,"twenty":5.782187,"median":10.348076,"eighty":53.820223,"marketCap":141131287},{"date":"2020-05-22","current":-47.867043,"twenty":5.767024,"median":10.315003,"eighty":53.820223,"marketCap":146805827},{"date":"2020-05-29","current":-49.359157,"twenty":5.76197,"median":10.290722,"eighty":53.820223,"marketCap":151382068},{"date":"2020-06-05","current":-50.910957,"twenty":5.746807,"median":10.247014,"eighty":53.820223,"marketCap":156141359},{"date":"2020-06-12","current":-48.642942,"twenty":5.731644,"median":10.19845,"eighty":53.820223,"marketCap":149185472},{"date":"2020-06-19","current":-49.418842,"twenty":5.706372,"median":10.154742,"eighty":53.820223,"marketCap":151565118},{"date":"2020-06-26","current":-47.628304,"twenty":5.660882,"median":10.111034,"eighty":53.820223,"marketCap":146073628},{"date":"2020-07-02","current":-48.881681,"twenty":5.610339,"median":10.101321,"eighty":53.820223,"marketCap":149917671},{"date":"2020-07-10","current":-48.404204,"twenty":5.559795,"median":10.07704,"eighty":53.820223,"marketCap":148453274},{"date":"2020-07-17","current":-48.762312,"twenty":5.529469,"median":10.06247,"eighty":53.820223,"marketCap":149551572},{"date":"2020-07-24","current":-48.642942,"twenty":5.51936,"median":10.047901,"eighty":53.820223,"marketCap":149185472},{"date":"2020-07-31","current":-49.120419,"twenty":5.509252,"median":9.994481,"eighty":53.820223,"marketCap":150649870},{"date":"2020-08-07","current":-50.015688,"twenty":5.489085,"median":9.945917,"eighty":53.820223,"marketCap":153395615},{"date":"2020-08-14","current":-50.373796,"twenty":5.478926,"median":9.921634,"eighty":53.820223,"marketCap":154493913},{"date":"2020-08-21","current":-50.135057,"twenty":5.458708,"median":9.882783,"eighty":53.820223,"marketCap":153761714},{"date":"2020-08-28","current":-50.254426,"twenty":5.448599,"median":9.834219,"eighty":53.820223,"marketCap":154127813},{"date":"2020-09-04","current":-49.239788,"twenty":5.443545,"median":9.76623,"eighty":53.820223,"marketCap":151015969},{"date":"2020-09-11","current":-49.120419,"twenty":5.438491,"median":9.722522,"eighty":53.820223,"marketCap":150649870},{"date":"2020-09-18","current":-49.239788,"twenty":5.428382,"median":9.683671,"eighty":53.820223,"marketCap":151015969},{"date":"2020-09-25","current":-49.359157,"twenty":5.413219,"median":9.586543,"eighty":53.820223,"marketCap":151382068},{"date":"2020-10-02","current":-48.284835,"twenty":5.408165,"median":9.503984,"eighty":53.820223,"marketCap":148087174},{"date":"2020-10-09","current":-49.478527,"twenty":5.40311,"median":9.275733,"eighty":53.820223,"marketCap":151748168},{"date":"2020-10-16","current":-49.060735,"twenty":5.387947,"median":9.028056,"eighty":53.820223,"marketCap":150466820},{"date":"2020-10-23","current":-49.280374,"twenty":5.377838,"median":8.853226,"eighty":53.820223,"marketCap":151140443},{"date":"2020-10-30","current":-46.912089,"twenty":5.347512,"median":8.405458,"eighty":53.820223,"marketCap":143877032},{"date":"2020-11-06","current":-12.633429,"twenty":-8.559637,"median":8.387574,"eighty":53.820223,"marketCap":152297317},{"date":"2020-11-13","current":-12.906749,"twenty":-8.650215,"median":8.362537,"eighty":53.162027,"marketCap":155592211},{"date":"2020-11-20","current":-12.967486,"twenty":-8.677389,"median":8.333922,"eighty":52.858243,"marketCap":156324409},{"date":"2020-11-27","current":-13.058441,"twenty":-8.704562,"median":8.333922,"eighty":52.7378,"marketCap":157420877},{"date":"2020-12-04","current":-13.073777,"twenty":-8.722678,"median":8.319615,"eighty":52.68865,"marketCap":157605757},{"date":"2020-12-11","current":-13.286359,"twenty":-8.740793,"median":8.312462,"eighty":52.605091,"marketCap":160168452},{"date":"2020-12-18","current":-13.438203,"twenty":-8.767967,"median":8.305308,"eighty":52.554461,"marketCap":161998949},{"date":"2020-12-24","current":-13.52931,"twenty":-8.777025,"median":8.298154,"eighty":52.50383,"marketCap":163097247},{"date":"2020-12-31","current":-13.286359,"twenty":-8.777025,"median":8.291001,"eighty":52.453199,"marketCap":160168452},{"date":"2021-01-08","current":-13.483756,"twenty":-8.804198,"median":8.287424,"eighty":52.442901,"marketCap":162548098},{"date":"2021-01-15","current":-13.407834,"twenty":-8.813256,"median":8.276694,"eighty":52.301308,"marketCap":161632849},{"date":"2021-01-22","current":-13.423019,"twenty":-8.822314,"median":8.255233,"eighty":52.246301,"marketCap":161815899},{"date":"2021-01-29","current":-13.028224,"twenty":-8.838636,"median":8.240926,"eighty":52.200047,"marketCap":157056608},{"date":"2021-02-05","current":-13.347097,"twenty":-8.849487,"median":8.226619,"eighty":52.149416,"marketCap":160900651},{"date":"2021-02-12","current":-13.468572,"twenty":-8.867603,"median":8.205158,"eighty":52.098852,"marketCap":162365048},{"date":"2021-02-19","current":-13.574863,"twenty":-8.884812,"median":8.190851,"eighty":52.049702,"marketCap":163646396},{"date":"2021-02-26","current":-13.544494,"twenty":-8.902022,"median":8.162236,"eighty":52.000552,"marketCap":163280296},{"date":"2021-03-05","current":-13.590047,"twenty":-8.912801,"median":8.122891,"eighty":51.951402,"marketCap":163829445},{"date":"2021-03-12","current":-14.045579,"twenty":-8.912892,"median":8.112161,"eighty":51.902252,"marketCap":169320935},{"date":"2021-03-19","current":-14.167055,"twenty":-8.931008,"median":8.037049,"eighty":51.803953,"marketCap":170785332},{"date":"2021-03-26","current":-14.303714,"twenty":-8.958181,"median":8.012011,"eighty":51.754803,"marketCap":172432779},{"date":"2021-04-01","current":-14.242977,"twenty":-8.985354,"median":7.904707,"eighty":51.705653,"marketCap":171700581},{"date":"2021-04-09","current":-14.334083,"twenty":-9.00338,"median":7.646857,"eighty":51.656503,"marketCap":172798879},{"date":"2021-04-16","current":-14.440374,"twenty":-9.012528,"median":7.496953,"eighty":51.558203,"marketCap":174080226},{"date":"2021-04-23","current":-14.326785,"twenty":-9.057817,"median":7.314215,"eighty":51.509053,"marketCap":172710901},{"date":"2021-04-30","current":-14.236205,"twenty":-9.123758,"median":7.21081,"eighty":51.459904,"marketCap":171618946},{"date":"2021-05-07","current":37.340073,"twenty":-9.166511,"median":7.167889,"eighty":51.410754,"marketCap":174712819},{"date":"2021-05-14","current":37.106697,"twenty":-9.166511,"median":7.278769,"eighty":51.410754,"marketCap":173620864},{"date":"2021-05-21","current":37.495656,"twenty":-9.166511,"median":7.436148,"eighty":51.410754,"marketCap":175440789},{"date":"2021-05-28","current":37.495656,"twenty":-9.166511,"median":7.600681,"eighty":51.410754,"marketCap":175440789},{"date":"2021-06-04","current":37.767928,"twenty":-9.166511,"median":7.761636,"eighty":51.410754,"marketCap":176714736},{"date":"2021-06-11","current":38.662534,"twenty":-9.166511,"median":7.976243,"eighty":51.410754,"marketCap":180900564},{"date":"2021-06-18","current":37.923511,"twenty":-9.166511,"median":8.028433,"eighty":51.410754,"marketCap":177442707},{"date":"2021-06-25","current":38.390262,"twenty":-9.166511,"median":8.097854,"eighty":51.410754,"marketCap":179626617},{"date":"2021-07-02","current":37.767928,"twenty":-9.166511,"median":8.119315,"eighty":51.410754,"marketCap":176714736},{"date":"2021-07-09","current":37.612344,"twenty":-9.166511,"median":8.151506,"eighty":51.410754,"marketCap":175986766},{"date":"2021-07-16","current":38.040199,"twenty":-9.166511,"median":8.18012,"eighty":51.410754,"marketCap":177988684},{"date":"2021-07-23","current":38.117991,"twenty":-9.166511,"median":8.201581,"eighty":51.410754,"marketCap":178352669},{"date":"2021-07-30","current":38.156887,"twenty":-9.166511,"median":8.223578,"eighty":51.410754,"marketCap":178534662},{"date":"2021-08-06","current":38.662534,"twenty":-9.166511,"median":8.233772,"eighty":51.410754,"marketCap":180900564},{"date":"2021-08-13","current":38.740325,"twenty":-9.162888,"median":8.248079,"eighty":51.406595,"marketCap":181264549},{"date":"2021-08-20","current":39.245972,"twenty":-9.162888,"median":8.276694,"eighty":51.406595,"marketCap":183630452},{"date":"2021-08-27","current":39.557139,"twenty":-9.162888,"median":8.283847,"eighty":51.406595,"marketCap":185086392},{"date":"2021-09-03","current":39.868307,"twenty":-9.162888,"median":8.291001,"eighty":51.406595,"marketCap":186542333},{"date":"2021-09-10","current":39.751619,"twenty":-9.143468,"median":8.298154,"eighty":51.406595,"marketCap":185996355},{"date":"2021-09-17","current":39.751619,"twenty":-9.143468,"median":8.298154,"eighty":51.406595,"marketCap":185996355},{"date":"2021-09-24","current":39.16818,"twenty":-9.139337,"median":8.312462,"eighty":51.406595,"marketCap":183266467},{"date":"2021-10-01","current":37.884615,"twenty":-8.820502,"median":8.319615,"eighty":51.406595,"marketCap":177260714},{"date":"2021-10-08","current":37.845719,"twenty":-8.813256,"median":8.330345,"eighty":51.402436,"marketCap":177078721},{"date":"2021-10-15","current":38.429158,"twenty":-8.813256,"median":8.333922,"eighty":51.402436,"marketCap":179808609},{"date":"2021-10-22","current":38.50695,"twenty":-8.811118,"median":8.362537,"eighty":51.402436,"marketCap":180172594},{"date":"2021-10-29","current":38.70143,"twenty":-8.713366,"median":8.387574,"eighty":51.402436,"marketCap":181082557},{"date":"2021-11-05","current":5.35719,"twenty":5.321229,"median":8.394728,"eighty":51.402436,"marketCap":181992520},{"date":"2021-11-12","current":5.480406,"twenty":5.321229,"median":8.377309,"eighty":51.402436,"marketCap":186178347},{"date":"2021-11-19","current":5.448262,"twenty":5.321229,"median":8.348229,"eighty":51.402436,"marketCap":185086392},{"date":"2021-11-26","current":5.426834,"twenty":5.321229,"median":8.333922,"eighty":51.402436,"marketCap":184358422},{"date":"2021-12-03","current":5.341119,"twenty":5.320694,"median":8.323407,"eighty":51.402436,"marketCap":181446542},{"date":"2021-12-10","current":5.421476,"twenty":5.320694,"median":8.312712,"eighty":51.402436,"marketCap":184176430},{"date":"2021-12-17","current":5.362547,"twenty":5.320694,"median":8.312462,"eighty":51.402436,"marketCap":182174512},{"date":"2021-12-23","current":5.587549,"twenty":5.314265,"median":8.298154,"eighty":51.402436,"marketCap":189818198},{"date":"2021-12-31","current":5.555406,"twenty":5.314265,"median":8.294577,"eighty":51.402436,"marketCap":188726243},{"date":"2022-01-07","current":5.458977,"twenty":5.317859,"median":8.291001,"eighty":51.398277,"marketCap":185450377},{"date":"2022-01-14","current":5.501834,"twenty":5.317859,"median":8.283776,"eighty":51.398277,"marketCap":186906318},{"date":"2022-01-21","current":5.233975,"twenty":5.303034,"median":8.276694,"eighty":51.398277,"marketCap":177806692},{"date":"2022-01-28","current":5.233975,"twenty":5.168617,"median":8.248079,"eighty":51.394118,"marketCap":177806692},{"date":"2022-02-04","current":5.282189,"twenty":5.168617,"median":8.230196,"eighty":51.394118,"marketCap":179444624},{"date":"2022-02-11","current":5.239332,"twenty":5.168617,"median":8.220001,"eighty":51.361604,"marketCap":177988684},{"date":"2022-02-18","current":5.142903,"twenty":5.160045,"median":8.194427,"eighty":51.273134,"marketCap":174712819},{"date":"2022-02-25","current":5.105402,"twenty":4.995044,"median":8.18012,"eighty":51.174834,"marketCap":173438871},{"date":"2022-03-04","current":5.094688,"twenty":4.995044,"median":8.151506,"eighty":51.076535,"marketCap":173074886},{"date":"2022-03-11","current":4.853614,"twenty":4.948972,"median":8.115738,"eighty":50.978235,"marketCap":164885223},{"date":"2022-03-18","current":5.137545,"twenty":4.909329,"median":8.094278,"eighty":50.879935,"marketCap":174530826},{"date":"2022-03-25","current":5.142903,"twenty":4.909329,"median":8.019164,"eighty":50.781635,"marketCap":174712819},{"date":"2022-04-01","current":5.089331,"twenty":4.909329,"median":7.929744,"eighty":50.683336,"marketCap":172892894},{"date":"2022-04-08","current":5.142903,"twenty":4.909329,"median":7.675793,"eighty":50.535886,"marketCap":174712819},{"date":"2022-04-14","current":5.105402,"twenty":4.909329,"median":7.568489,"eighty":50.398267,"marketCap":173438871},{"date":"2022-04-22","current":5.067902,"twenty":4.909329,"median":7.414687,"eighty":49.985408,"marketCap":172164923},{"date":"2022-04-29","current":5.01433,"twenty":4.909329,"median":7.257308,"eighty":49.552889,"marketCap":170344998},{"date":"2022-05-06","current":7.032916,"twenty":4.909329,"median":7.189349,"eighty":48.845131,"marketCap":169435036},{"date":"2022-05-13","current":7.010253,"twenty":4.909329,"median":7.189349,"eighty":48.845131,"marketCap":168889058},{"date":"2022-05-20","current":6.889387,"twenty":4.909329,"median":7.189349,"eighty":48.845131,"marketCap":165977178},{"date":"2022-05-27","current":7.244432,"twenty":4.909329,"median":7.21081,"eighty":48.845131,"marketCap":174530826},{"date":"2022-06-03","current":7.093349,"twenty":4.909329,"median":7.235848,"eighty":48.845131,"marketCap":170890976},{"date":"2022-06-10","current":7.010253,"twenty":4.909329,"median":7.235848,"eighty":48.845131,"marketCap":168889058},{"date":"2022-06-17","current":6.557004,"twenty":4.909329,"median":7.235848,"eighty":48.845131,"marketCap":157969507},{"date":"2022-06-24","current":6.844062,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":164885223},{"date":"2022-07-01","current":6.828954,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":164521238},{"date":"2022-07-08","current":6.894524,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":166100933},{"date":"2022-07-15","current":6.798737,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":163793268},{"date":"2022-07-22","current":6.73075,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":162155335},{"date":"2022-07-29","current":6.904495,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":166341163},{"date":"2022-08-05","current":6.919603,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":166705148},{"date":"2022-08-12","current":7.055578,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":169981013},{"date":"2022-08-19","current":7.010253,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":168889058},{"date":"2022-08-26","current":6.957374,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":167615110},{"date":"2022-09-02","current":6.821399,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":164339245},{"date":"2022-09-09","current":6.964928,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":167797103},{"date":"2022-09-16","current":6.745858,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":162519320},{"date":"2022-09-23","current":6.451246,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":155421612},{"date":"2022-09-30","current":6.36815,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":153419694},{"date":"2022-10-07","current":6.232176,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":150143829},{"date":"2022-10-14","current":6.186851,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":149051873},{"date":"2022-10-21","current":6.300163,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":151781761},{"date":"2022-10-28","current":6.526788,"twenty":4.8954,"median":7.239424,"eighty":48.884451,"marketCap":157241537},{"date":"2022-11-04","current":3557.773003,"twenty":4.8954,"median":7.25954,"eighty":49.33663,"marketCap":158879469},{"date":"2022-11-11","current":3602.601765,"twenty":4.8954,"median":7.324623,"eighty":49.955918,"marketCap":160881387},{"date":"2022-11-18","current":3618.903128,"twenty":4.8954,"median":7.518414,"eighty":50.182007,"marketCap":161609357},{"date":"2022-11-25","current":3667.807242,"twenty":4.8954,"median":7.632227,"eighty":50.496566,"marketCap":163793268},{"date":"2022-12-02","current":3675.957924,"twenty":4.8954,"median":7.883247,"eighty":50.644016,"marketCap":164157253},{"date":"2022-12-09","current":3618.903128,"twenty":4.8954,"median":8.012011,"eighty":50.771805,"marketCap":161609357},{"date":"2022-12-16","current":3606.677117,"twenty":4.8954,"median":8.040625,"eighty":50.870105,"marketCap":161063380},{"date":"2022-12-23","current":3631.129162,"twenty":4.8954,"median":8.112161,"eighty":50.968405,"marketCap":162155335},{"date":"2022-12-30","current":3545.546992,"twenty":4.8954,"median":8.119315,"eighty":51.017555,"marketCap":158333492},{"date":"2023-01-06","current":3631.129162,"twenty":4.8954,"median":8.155083,"eighty":51.115855,"marketCap":162155335},{"date":"2023-01-13","current":3643.355174,"twenty":4.8954,"median":8.183697,"eighty":51.214154,"marketCap":162701312},{"date":"2023-01-20","current":3618.903128,"twenty":4.8954,"median":8.205158,"eighty":51.312454,"marketCap":161609357},{"date":"2023-01-27","current":3680.033253,"twenty":4.8954,"median":8.226619,"eighty":51.381264,"marketCap":164339245},{"date":"2023-02-03","current":3671.882572,"twenty":4.8954,"median":8.233772,"eighty":51.459904,"marketCap":163975260},{"date":"2023-02-10","current":3643.355174,"twenty":4.8954,"median":8.248079,"eighty":51.509053,"marketCap":162701312},{"date":"2023-02-17","current":3688.183935,"twenty":4.8954,"median":8.276694,"eighty":51.577863,"marketCap":164703230},{"date":"2023-02-24","current":3627.05381,"twenty":4.8954,"median":8.283847,"eighty":51.656503,"marketCap":161973342},{"date":"2023-03-03","current":3627.05381,"twenty":4.8954,"median":8.291001,"eighty":51.705653,"marketCap":161973342},{"date":"2023-03-10","current":3508.868912,"twenty":4.8954,"median":8.298154,"eighty":51.754803,"marketCap":156695559},{"date":"2023-03-17","current":3402.910048,"twenty":4.8954,"median":8.312462,"eighty":51.902252,"marketCap":151963754},{"date":"2023-03-24","current":3402.910048,"twenty":4.8954,"median":8.312462,"eighty":52.000552,"marketCap":151963754},{"date":"2023-03-31","current":3480.341537,"twenty":4.909329,"median":8.319615,"eighty":52.049702,"marketCap":155421612},{"date":"2023-04-06","current":3382.533332,"twenty":4.909329,"median":8.330345,"eighty":52.098852,"marketCap":151053791},{"date":"2023-04-14","current":3459.964821,"twenty":4.8954,"median":8.333922,"eighty":52.216811,"marketCap":154511649},{"date":"2023-04-21","current":3427.362093,"twenty":4.8954,"median":8.362537,"eighty":52.413411,"marketCap":153055709},{"date":"2023-04-28","current":3435.512775,"twenty":4.8954,"median":8.391151,"eighty":52.56086,"marketCap":153419694},{"date":"2023-05-05","current":3378.458002,"twenty":4.8954,"median":8.405458,"eighty":52.983549,"marketCap":150871799},{"date":"2023-05-12","current":34.072027,"twenty":4.8954,"median":8.88722,"eighty":52.983549,"marketCap":151599769},{"date":"2023-05-19","current":34.194735,"twenty":4.8954,"median":9.071764,"eighty":52.983549,"marketCap":152145746},{"date":"2023-05-26","current":33.458485,"twenty":4.8954,"median":9.285445,"eighty":52.983549,"marketCap":148869881},{"date":"2023-06-02","current":33.253971,"twenty":4.8954,"median":9.499127,"eighty":52.983549,"marketCap":147959918},{"date":"2023-06-09","current":34.031124,"twenty":4.8954,"median":9.57683,"eighty":52.983549,"marketCap":151417776},{"date":"2023-06-16","current":34.399249,"twenty":4.8954,"median":9.683671,"eighty":52.983549,"marketCap":153055709},{"date":"2023-06-23","current":34.194735,"twenty":4.881472,"median":9.707953,"eighty":52.983549,"marketCap":152145746},{"date":"2023-06-30","current":34.399249,"twenty":4.867543,"median":9.761373,"eighty":52.983549,"marketCap":153055709},{"date":"2023-07-07","current":33.785707,"twenty":4.867543,"median":9.81965,"eighty":52.983549,"marketCap":150325821},{"date":"2023-07-14","current":34.644666,"twenty":4.867543,"median":9.877927,"eighty":52.983549,"marketCap":154147664},{"date":"2023-07-21","current":34.521957,"twenty":4.867543,"median":9.907065,"eighty":52.983549,"marketCap":153601686},{"date":"2023-07-28","current":34.276541,"twenty":4.867543,"median":9.945917,"eighty":52.983549,"marketCap":152509731},{"date":"2023-08-04","current":34.399249,"twenty":4.867543,"median":9.965342,"eighty":52.983549,"marketCap":153055709},{"date":"2023-08-11","current":34.521957,"twenty":4.867543,"median":10.033332,"eighty":52.983549,"marketCap":153601686},{"date":"2023-08-18","current":34.031124,"twenty":4.867543,"median":10.052757,"eighty":52.983549,"marketCap":151417776},{"date":"2023-08-25","current":34.276541,"twenty":4.867543,"median":10.072183,"eighty":52.983549,"marketCap":152509731},{"date":"2023-09-01","current":34.84918,"twenty":4.867543,"median":10.091609,"eighty":52.983549,"marketCap":155057627},{"date":"2023-09-08","current":33.949318,"twenty":4.853614,"median":10.101321,"eighty":52.983549,"marketCap":151053791},{"date":"2023-09-15","current":33.908416,"twenty":4.849328,"median":10.13046,"eighty":53.052359,"marketCap":150871799},{"date":"2023-09-22","current":34.378798,"twenty":4.845043,"median":10.174167,"eighty":53.121169,"marketCap":152964713},{"date":"2023-09-29","current":34.153832,"twenty":4.840757,"median":10.208162,"eighty":53.189978,"marketCap":151963754},{"date":"2023-10-06","current":32.313206,"twenty":4.840757,"median":10.256726,"eighty":53.189978,"marketCap":143774090},{"date":"2023-10-13","current":32.967651,"twenty":4.836472,"median":10.300434,"eighty":53.258788,"marketCap":146685971},{"date":"2023-10-17","current":33.294874,"twenty":4.836472,"median":10.310147,"eighty":53.258788,"marketCap":148141911},{"date":"2023-10-23","current":32.354109,"twenty":-2.15406,"median":10.315003,"eighty":161.931464,"marketCap":143956083},{"date":"2023-11-01","current":32.395012,"twenty":-12.660761,"median":10.363567,"eighty":325.249102,"marketCap":144138075},{"date":"2023-11-10","current":20.679532,"twenty":-12.715425,"median":20.679532,"eighty":326.072779,"marketCap":145958001},{"date":"2023-11-17","current":21.362834,"twenty":-12.715425,"median":21.092092,"eighty":326.072779,"marketCap":150780802},{"date":"2023-11-24","current":21.81407,"twenty":-12.715425,"median":21.478866,"eighty":326.072779,"marketCap":153965671},{"date":"2023-12-01","current":21.736715,"twenty":-12.715425,"median":21.736715,"eighty":326.072779,"marketCap":153419694},{"date":"2023-12-08","current":21.96878,"twenty":-12.688093,"median":21.81407,"eighty":325.66094,"marketCap":155057627},{"date":"2023-12-15","current":22.639189,"twenty":-12.688093,"median":22.059027,"eighty":325.66094,"marketCap":159789432},{"date":"2023-12-22","current":22.17506,"twenty":-12.688093,"median":22.329769,"eighty":325.66094,"marketCap":156513567},{"date":"2023-12-29","current":21.7625,"twenty":-12.715425,"median":22.381339,"eighty":326.072779,"marketCap":153601686},{"date":"2024-01-05","current":21.736715,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":153419694},{"date":"2024-01-12","current":22.149275,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":156331574},{"date":"2024-01-19","current":22.355554,"twenty":-12.770089,"median":22.432909,"eighty":326.896455,"marketCap":157787514},{"date":"2024-01-26","current":22.07192,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":155785597},{"date":"2024-02-02","current":22.22663,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":156877552},{"date":"2024-02-09","current":22.097705,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":155967589},{"date":"2024-02-16","current":22.07192,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":155785597},{"date":"2024-02-23","current":22.256024,"twenty":-12.742757,"median":22.407124,"eighty":326.484617,"marketCap":157085023},{"date":"2024-03-01","current":22.097705,"twenty":-12.715425,"median":22.381339,"eighty":326.072779,"marketCap":155967589},{"date":"2024-03-08","current":22.303984,"twenty":-12.715425,"median":22.381339,"eighty":326.072779,"marketCap":157423529},{"date":"2024-03-15","current":22.458694,"twenty":-12.715425,"median":22.510264,"eighty":326.072779,"marketCap":158515484},{"date":"2024-03-22","current":22.845468,"twenty":-12.715425,"median":22.613404,"eighty":326.072779,"marketCap":161245372},{"date":"2024-03-28","current":23.103318,"twenty":-12.715425,"median":22.742329,"eighty":326.072779,"marketCap":163065297},{"date":"2024-04-05","current":22.432909,"twenty":-12.742757,"median":22.819683,"eighty":326.484617,"marketCap":158333492},{"date":"2024-04-12","current":22.407124,"twenty":-12.742757,"median":22.819683,"eighty":326.484617,"marketCap":158151499},{"date":"2024-04-19","current":21.839855,"twenty":-12.742757,"median":22.819683,"eighty":326.484617,"marketCap":154147664},{"date":"2024-04-26","current":22.948608,"twenty":-12.715425,"median":22.948608,"eighty":326.072779,"marketCap":161973342},{"date":"2024-05-03","current":22.587619,"twenty":-12.715425,"median":23.000178,"eighty":326.072779,"marketCap":159425447},{"date":"2024-05-10","current":22.819684,"twenty":-12.715425,"median":22.948608,"eighty":326.072779,"marketCap":161063380},{"date":"2024-05-17","current":15.22155,"twenty":-12.715425,"median":22.793898,"eighty":326.072779,"marketCap":163065297},{"date":"2024-05-24","current":14.898771,"twenty":-12.715425,"median":22.742329,"eighty":326.072779,"marketCap":159607440},{"date":"2024-05-31","current":14.830818,"twenty":-12.715425,"median":22.639189,"eighty":326.072779,"marketCap":158879469},{"date":"2024-06-07","current":14.958231,"twenty":-12.715425,"median":22.587619,"eighty":326.072779,"marketCap":160244413},{"date":"2024-06-14","current":15.051666,"twenty":-12.742757,"median":22.510264,"eighty":326.484617,"marketCap":161245372},{"date":"2024-06-21","current":14.949736,"twenty":-12.770089,"median":22.458694,"eighty":326.896455,"marketCap":160153417},{"date":"2024-06-28","current":15.051666,"twenty":-12.806532,"median":22.420016,"eighty":336.780568,"marketCap":161245372},{"date":"2024-07-05","current":14.932748,"twenty":-12.806532,"median":22.342661,"eighty":336.780568,"marketCap":159971425},{"date":"2024-07-12","current":15.11962,"twenty":-12.806532,"median":22.303984,"eighty":336.780568,"marketCap":161973342},{"date":"2024-07-15","current":15.306492,"twenty":-12.806532,"median":22.291092,"eighty":336.780568,"marketCap":163975260},{"date":"2024-08-02","current":15.52734,"twenty":-12.870306,"median":22.252414,"eighty":354.489605,"marketCap":166341163},{"date":"2024-08-09","current":15.391433,"twenty":-12.870306,"median":22.200845,"eighty":354.489605,"marketCap":164885223},{"date":"2024-08-16","current":15.680235,"twenty":-12.870306,"median":22.12349,"eighty":354.489605,"marketCap":167979095},{"date":"2024-08-23","current":15.884095,"twenty":-12.870306,"median":22.097705,"eighty":354.489605,"marketCap":170163006},{"date":"2024-08-30","current":16.002843,"twenty":-12.870306,"median":22.097705,"eighty":354.489605,"marketCap":171435133},{"date":"2024-09-06","current":15.867107,"twenty":-12.870306,"median":22.07192,"eighty":354.489605,"marketCap":169981013},{"date":"2024-09-13","current":15.870504,"twenty":-12.870306,"median":22.046135,"eighty":354.489605,"marketCap":170017412},{"date":"2024-09-20","current":16.03699,"twenty":-12.870306,"median":21.994565,"eighty":354.489605,"marketCap":171800938},{"date":"2024-09-27","current":15.952048,"twenty":-12.870306,"median":21.96878,"eighty":354.489605,"marketCap":170890976},{"date":"2024-10-04","current":15.782165,"twenty":-12.870306,"median":21.839855,"eighty":354.489605,"marketCap":169071051},{"date":"2024-10-11","current":16.053978,"twenty":-12.870306,"median":21.81407,"eighty":354.489605,"marketCap":171982931},{"date":"2024-10-18","current":16.206873,"twenty":-12.870306,"median":21.7625,"eighty":354.489605,"marketCap":173620864},{"date":"2024-10-25","current":16.172897,"twenty":-12.870306,"median":21.530436,"eighty":354.489605,"marketCap":173256879},{"date":"2024-10-31","current":15.93557,"twenty":-12.870306,"median":21.401511,"eighty":354.489605,"marketCap":170714443},{"date":"2024-11-08","current":8.091089,"twenty":-12.879417,"median":21.001845,"eighty":356.342875,"marketCap":171618946},{"date":"2024-11-15","current":8.108249,"twenty":-12.879417,"median":16.283321,"eighty":153.879227,"marketCap":171982931},{"date":"2024-11-22","current":8.254112,"twenty":-12.879417,"median":16.194132,"eighty":39.844969,"marketCap":175076804},{"date":"2024-11-29","current":8.339913,"twenty":-12.879417,"median":16.130426,"eighty":39.751619,"marketCap":176896729},{"date":"2024-12-06","current":8.236952,"twenty":-12.879417,"median":16.079461,"eighty":39.557139,"marketCap":174712819},{"date":"2024-12-13","current":8.013867,"twenty":-12.879417,"median":16.028496,"eighty":39.277089,"marketCap":169981013},{"date":"2024-12-20","current":7.833684,"twenty":-12.879417,"median":15.994434,"eighty":39.144843,"marketCap":166159170},{"date":"2024-12-27","current":8.13399,"twenty":-12.879417,"median":15.943809,"eighty":39.012597,"marketCap":172528908},{"date":"2025-01-03","current":7.893745,"twenty":-12.879417,"median":15.918072,"eighty":38.973701,"marketCap":167433118},{"date":"2025-01-10","current":7.936646,"twenty":-12.888527,"median":15.884095,"eighty":38.880351,"marketCap":168343081},{"date":"2025-01-17","current":8.095379,"twenty":-12.888527,"median":15.850118,"eighty":38.740325,"marketCap":171709942},{"date":"2025-01-24","current":8.14257,"twenty":-12.888527,"median":15.816142,"eighty":38.685872,"marketCap":172710901},{"date":"2025-01-31","current":8.15115,"twenty":-12.888527,"median":15.799153,"eighty":38.646976,"marketCap":172892894},{"date":"2025-02-07","current":8.031028,"twenty":-12.888527,"median":15.578305,"eighty":38.50695,"marketCap":170344998},{"date":"2025-02-14","current":8.228371,"twenty":-12.888527,"median":15.391433,"eighty":38.429158,"marketCap":174530826},{"date":"2025-02-21","current":8.279852,"twenty":-12.888527,"median":15.238538,"eighty":38.296913,"marketCap":175622781},{"date":"2025-02-28","current":16.359768,"twenty":-12.888527,"median":15.238538,"eighty":38.195783,"marketCap":175258796},{"date":"2025-03-07","current":16.359768,"twenty":-12.897638,"median":15.230044,"eighty":38.117991,"marketCap":175258796},{"date":"2025-03-14","current":16.104943,"twenty":-12.897638,"median":15.230044,"eighty":38.040199,"marketCap":172528908},{"date":"2025-03-21","current":16.609497,"twenty":-12.897638,"median":15.230044,"eighty":37.845719,"marketCap":177934086},{"date":"2025-03-28","current":16.631582,"twenty":-12.897638,"median":15.230044,"eighty":37.830161,"marketCap":178170677},{"date":"2025-04-04","current":16.359768,"twenty":-12.897638,"median":15.230044,"eighty":37.721253,"marketCap":175258796},{"date":"2025-04-11","current":15.612282,"twenty":-12.888527,"median":15.22155,"eighty":37.674578,"marketCap":167251125},{"date":"2025-04-17","current":15.918072,"twenty":-12.888527,"median":15.22155,"eighty":37.612344,"marketCap":170526991},{"date":"2025-04-25","current":16.85243,"twenty":-12.897638,"median":15.213056,"eighty":37.495656,"marketCap":180536579},{"date":"2025-04-28","current":16.64857,"twenty":-12.897638,"median":15.213056,"eighty":37.495656,"marketCap":178352669}],"updateTime":1745933080845}}}